Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription

Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription

Show other versions (1)

Introduction: None of the approved immunomodulatory drugs in adults Multiple Sclerosis (MS) patients have been officially approved for the pediatric patients and are currently used off-label in this population. Objectives: In this study, we evaluated the effectiveness and tolerability of intramuscul...

Full description

Bibliographic Details
Main Authors: Amir Hadi Maghzi, Zahra Fatehi, Vahid Shaygannejad, Fereshteh Ashtari, Fatemeh Derakhshan, Masood Etemadifar, Keivan Basiri, Farzad Fatehi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-02-01
Series:Acta Medica Iranica
Subjects:
Multiple Sclerosis
Pediatrics
Childhood
Interferons
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/20205.pdf&manuscript_id=20205

Internet

http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/20205.pdf&manuscript_id=20205

Similar Items